Jean-claude Chomel

Poitiers, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Innate CD8 T-cells as a potential predictive biomarker for deep molecular response in chronic myeloid leukemia patients.

Innate CD8 T-cells as a potential predictive biomarker for deep molecular response in chronic myeloid leukemia patients.

Journal: Cancer immunology, immunotherapy : CII
Published: September 11, 2025

Emergence of secondary fusions in chronic myeloid leukemia as a driver of tyrosine kinase inhibitor resistance and blast crisis transformation.

Emergence of secondary fusions in chronic myeloid leukemia as a driver of tyrosine kinase inhibitor resistance and blast crisis transformation.

Journal: Leukemia research
Published: November 17, 2023

Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis.

Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis.

Journal: International journal of molecular sciences
Published: September 27, 2023

ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia

ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: April 07, 2023

Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms.

Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms.

Journal: British journal of haematology
Published: February 17, 2023

Hairy cell leukemia with isolated bone lesions.

Hairy cell leukemia with isolated bone lesions.

Journal: Clinical case reports
Published: January 01, 2023

Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs).

Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs).

Journal: Cells
Published: December 29, 2022

Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).

Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).

Journal: British journal of haematology
Published: May 13, 2022

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.

Journal: Blood cancer journal
Published: February 07, 2022

Identification and genetic characterization of a NUP98-HHEX molecular rearrangement in a pediatric acute myeloid leukemia.

Identification and genetic characterization of a NUP98-HHEX molecular rearrangement in a pediatric acute myeloid leukemia.

Journal: Leukemia & lymphoma
Published: August 17, 2021

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.

Journal: Blood advances
Published: September 18, 2020

Reply to Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study.

Reply to Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study.

Journal: Cancer
Published: September 08, 2020
Showing 1-12 of 37

Last Updated: 09/26/2026